Correction: Efficacy of NKG2D CAR-T cells with IL-15/IL-15Rα signaling for treating Epstein-Barr virus-associated lymphoproliferative disorder.
作者信息
Mai Qiusui, He Bailin, Deng Shikai, Zeng Qing, Xu Yanwen, Wang Cong, Pang Yunyi, Zhang Sheng, Li Jinfeng, Zeng Jinfeng, Huang Liqin, Fu Yongshui, Li Chengyao, Li Tingting, Xu Xiaojun, Zhang Ling
机构信息
Department of Blood Transfusion, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, 518107, China.
Department of Transfusion Medicine, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, 510515, China.
出版信息
Exp Hematol Oncol. 2024 Sep 12;13(1):93. doi: 10.1186/s40164-024-00559-7.
Abstract
摘要
相似文献
1
Correction: Efficacy of NKG2D CAR-T cells with IL-15/IL-15Rα signaling for treating Epstein-Barr virus-associated lymphoproliferative disorder.更正：具有IL-15/IL-15Rα信号传导的NKG2D嵌合抗原受体T细胞治疗爱泼斯坦-巴尔病毒相关淋巴增殖性疾病的疗效。
Exp Hematol Oncol. 2024 Sep 12;13(1):93. doi: 10.1186/s40164-024-00559-7.
2
Efficacy of NKG2D CAR-T cells with IL-15/IL-15Rα signaling for treating Epstein-Barr virus-associated lymphoproliferative disorder.具有IL-15/IL-15Rα信号传导的NKG2D嵌合抗原受体T细胞治疗爱泼斯坦-巴尔病毒相关淋巴增殖性疾病的疗效
Exp Hematol Oncol. 2024 Aug 19;13(1):85. doi: 10.1186/s40164-024-00553-z.
3
CAR-T cells and TRUCKs that recognize an EBNA-3C-derived epitope presented on HLA-B*35 control Epstein-Barr virus-associated lymphoproliferation.CAR-T 细胞和 TRUCKs 识别 HLA-B*35 呈递的 EBNA-3C 衍生表位，从而控制 EBV 相关淋巴增殖。
J Immunother Cancer. 2020 Oct;8(2). doi: 10.1136/jitc-2020-000736.
4
Favorable outcome of Epstein-Barr virus-associated B-cell lymphoproliferative disorder complicated by immunoglobulin G4-related disease treated with rituximab-based therapy: a case report.利妥昔单抗治疗的爱泼斯坦-巴尔病毒相关B细胞淋巴增殖性疾病合并免疫球蛋白G4相关疾病的良好结局：病例报告
J Med Case Rep. 2016 Aug 24;10(1):236. doi: 10.1186/s13256-016-1009-1.
5
Methotrexate-associated lymphoproliferative disorders of T-cell phenotype: clinicopathological analysis of 28 cases.甲氨蝶呤相关性 T 细胞表型淋巴增生性疾病：28 例临床病理分析。
Mod Pathol. 2019 Jul;32(8):1135-1146. doi: 10.1038/s41379-019-0264-2. Epub 2019 Apr 5.
6
Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders.爱泼斯坦-巴尔病毒阳性T/NK细胞淋巴增殖性疾病
Exp Mol Med. 2015 Jan 23;47(1):e133. doi: 10.1038/emm.2014.105.
7
8
Epstein-Barr virus DNAemia in Iranian liver transplant recipients and assessment of its variation in posttransplant lymphproliferative disorder patients by quantitative polymerase chain reaction assay.伊朗肝移植受者中的爱泼斯坦-巴尔病毒血症以及通过定量聚合酶链反应测定评估移植后淋巴增殖性疾病患者中该病毒的变异情况。
Exp Clin Transplant. 2015 Apr;13 Suppl 1:306-11. doi: 10.6002/ect.mesot2014.p148.
9
Systematic Epstein-Barr virus-positive T-cell lymphoproliferative disease presenting as a persistent fever and cough: a case report.以持续发热和咳嗽为表现的系统性爱泼斯坦-巴尔病毒阳性T细胞淋巴增殖性疾病：一例报告
J Med Case Rep. 2014 Aug 27;8:288. doi: 10.1186/1752-1947-8-288.
10
Co-expression of IL-21-Enhanced NKG2D CAR-NK cell therapy for lung cancer.IL-21 增强的 NKG2D CAR-NK 细胞疗法治疗肺癌。
BMC Cancer. 2024 Jan 23;24(1):119. doi: 10.1186/s12885-023-11806-1.
本文引用的文献
1
Efficacy of NKG2D CAR-T cells with IL-15/IL-15Rα signaling for treating Epstein-Barr virus-associated lymphoproliferative disorder.具有IL-15/IL-15Rα信号传导的NKG2D嵌合抗原受体T细胞治疗爱泼斯坦-巴尔病毒相关淋巴增殖性疾病的疗效
Exp Hematol Oncol. 2024 Aug 19;13(1):85. doi: 10.1186/s40164-024-00553-z.
Zotero 插件